Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B0V

Crystal Structure of human monoamine oxidase B in complex with (E)-3-phenyl-1-(3-(trifluoromethyl)phenyl)prop-2-en-1-one

Summary for 7B0V
Entry DOI10.2210/pdb7b0v/pdb
DescriptorAmine oxidase [flavin-containing] B, FLAVIN-ADENINE DINUCLEOTIDE, (E)-3-phenyl-1-(3-(trifluoromethyl)phenyl)prop-2-en-1-one, ... (6 entities in total)
Functional Keywordsmonoamine oxidase, drug target, neurodegeneration, flavin, chalcone, mitochondrial membrane, flavoprotein
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight120656.36
Authors
Iacovino, L.G.,Binda, C. (deposition date: 2020-11-23, release date: 2021-11-03, Last modification date: 2024-11-06)
Primary citationIacovino, L.G.,Pinzi, L.,Facchetti, G.,Bortolini, B.,Christodoulou, M.S.,Binda, C.,Rastelli, G.,Rimoldi, I.,Passarella, D.,Di Paolo, M.L.,Dalla Via, L.
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
Acs Med.Chem.Lett., 12:1151-1158, 2021
Cited by
PubMed Abstract: A library of monosubstituted chalcones (-) bearing electron-donating and electron-withdrawing groups on both aromatic rings were selected. The cell viability on human tumor cell lines was evaluated first. The compounds unable to induce detectable cytotoxicity (, , and ) were tested using the monoamine oxidase (MAO) activity assay. Interestingly, they inhibit MAO-B, acting as competitive inhibitors, with and showing the best profiles. In particular, exhibited a potency higher than that of safinamide, taken as a reference. Docking studies and crystallographic analysis showed that in human MAO-B binds with the halogen-substituted aromatic ring in the entrance cavity, similar to safinamide, whereas is accommodated in the opposite way. The main conclusion of this cell biology, biochemistry, and structural study is to highlights as a chalcone derivative that is worth consideration for the development of novel MAO-B-selective inhibitors for the treatment of neurodegenerative diseases.
PubMed: 34262643
DOI: 10.1021/acsmedchemlett.1c00238
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon